Tapewire

Nasdaq · USD

NTRA

Natera, Inc.

Export transactions ↓
Tapewire entity
2635
SEC CIK
0001604821
Parsed reports
1,197

Last 12 months

Inside the activity.

0 purchase rows · 457 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025047
Dec 2025021
Jan 2026041
Feb 2026021
Mar 2026054
Apr 2026029
May 2026033
Jun 2026068
Jul 2026047
Aug 2026033
Sep 2026059
Oct 202604

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2024 Filed Oct 4, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 729 $126.27 $92,051.05
Disclosure

SEC source: 0001415889-24-024709 · form4-10032024_091001.xml · nonDerivative · entry 5

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Indirect · By Caraluna 1 Trust

Disclosed balance after: 57,432

F5 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.

F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.78 to $126.5050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
October 01, 2024 Filed Oct 4, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 771 $125.23 $96,550.33
Disclosure

SEC source: 0001415889-24-024709 · form4-10032024_091001.xml · nonDerivative · entry 4

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Indirect · By Caraluna 1 Trust

Disclosed balance after: 58,161

F5 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.

F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.78 to $125.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
October 01, 2024 Filed Oct 4, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 427 $126.42 $53,981.60
Disclosure

SEC source: 0001415889-24-024709 · form4-10032024_091001.xml · nonDerivative · entry 3

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 282,041

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.33 to $126.5050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 01, 2024 Filed Oct 4, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 1,397 $125.83 $175,785.21
Disclosure

SEC source: 0001415889-24-024709 · form4-10032024_091001.xml · nonDerivative · entry 2

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 282,468

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.32 to $126.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 01, 2024 Filed Oct 4, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 876 $124.82 $109,346.17
Disclosure

SEC source: 0001415889-24-024709 · form4-10032024_091001.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 283,865

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.27 to $125.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 18, 2024 Filed Sep 21, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 3,066 $128.07 $392,677.34
Disclosure

SEC source: 0001415889-24-023812 · form4-09202024_090901.xml · nonDerivative · entry 6

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Indirect · By Caraluna 2 Trust

Disclosed balance after: 58,932

F4 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.

F9 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.8100 to $128.2650 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
September 18, 2024 Filed Sep 21, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 6,584 $127.39 $838,704.16
Disclosure

SEC source: 0001415889-24-023812 · form4-09202024_090901.xml · nonDerivative · entry 5

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Indirect · By Caraluna 2 Trust

Disclosed balance after: 61,998

F4 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.

F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.7950 to $127.7800 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
September 18, 2024 Filed Sep 21, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 3,246 $128.06 $415,677.89
Disclosure

SEC source: 0001415889-24-023812 · form4-09202024_090901.xml · nonDerivative · entry 4

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Indirect · By Caraluna 1 Trust

Disclosed balance after: 58,932

F4 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.

F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.8400 to $128.3250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
September 18, 2024 Filed Sep 21, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 6,404 $127.38 $815,728.07
Disclosure

SEC source: 0001415889-24-023812 · form4-09202024_090901.xml · nonDerivative · entry 3

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Indirect · By Caraluna 1 Trust

Disclosed balance after: 62,178

F4 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.7950 to $127.7500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
September 18, 2024 Filed Sep 21, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 778 $128.06 $99,628.35
Disclosure

SEC source: 0001415889-24-023812 · form4-09202024_090901.xml · nonDerivative · entry 2

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 284,741

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.85 to $128.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 18, 2024 Filed Sep 21, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 1,922 $127.38 $244,821.67
Disclosure

SEC source: 0001415889-24-023812 · form4-09202024_090901.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 285,519

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.7950 to $127.7400 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 16, 2024 Filed Sep 19, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 500 $130.93 $65,466.00
Disclosure

SEC source: 0001415889-24-023669 · form4-09182024_090901.xml · nonDerivative · entry 5

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 195,686

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.

F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.83 to $131.18 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 16, 2024 Filed Sep 19, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 598 $129.90 $77,677.99
Disclosure

SEC source: 0001415889-24-023669 · form4-09182024_090901.xml · nonDerivative · entry 4

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 196,186

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.6400 to $130.3450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 16, 2024 Filed Sep 19, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 1,626 $128.87 $209,539.21
Disclosure

SEC source: 0001415889-24-023669 · form4-09182024_090901.xml · nonDerivative · entry 3

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 196,784

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.46 to $129.44 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 16, 2024 Filed Sep 19, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 1,258 $127.83 $160,806.87
Disclosure

SEC source: 0001415889-24-023669 · form4-09182024_090901.xml · nonDerivative · entry 2

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 198,410

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.41 to $128.40 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 16, 2024 Filed Sep 19, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 1,042 $126.66 $131,983.99
Disclosure

SEC source: 0001415889-24-023669 · form4-09182024_090901.xml · nonDerivative · entry 1

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 199,668

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.3500 to $126.8350 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 13, 2024 Filed Sep 17, 2024 01:05 UTC Exercise / conversionStock Option (right to buy) · Derivative 2,614 $0.00 Strike: $94.14 $0.00
Disclosure

SEC source: 0001415889-24-023469 · form4-09162024_090901.xml · derivative · entry 3

Chapman Rowan E · CIK 0001786240 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,614 shares

Expires 2031-05-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
September 13, 2024 Filed Sep 17, 2024 01:05 UTC SaleCommon Stock 2,614 $127.68 $333,755.52
Disclosure

SEC source: 0001415889-24-023469 · form4-09162024_090901.xml · nonDerivative · entry 2

Chapman Rowan E · CIK 0001786240 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,969

Read SEC document
September 13, 2024 Filed Sep 17, 2024 01:05 UTC Exercise / conversionCommon Stock 2,614 $94.14 $246,081.96
Disclosure

SEC source: 0001415889-24-023469 · form4-09162024_090901.xml · nonDerivative · entry 1

Chapman Rowan E · CIK 0001786240 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,583

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2024 Filed Aug 17, 2024 01:40 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 577 $120.00 $69,240.00
Disclosure

SEC source: 0001415889-24-021534 · form4-08162024_090804.xml · nonDerivative · entry 2

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 200,710

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.

Read SEC document
August 15, 2024 Filed Aug 17, 2024 01:40 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 5,006 $118.79 $594,655.23
Disclosure

SEC source: 0001415889-24-021534 · form4-08162024_090804.xml · nonDerivative · entry 1

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 201,287

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.51 to $119.3050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 15, 2024 Filed Aug 17, 2024 01:40 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 12,000 $121.01 $1,452,124.80
Disclosure

SEC source: 0001415889-24-021533 · form4-08162024_090801.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 287,441

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 13, 2024 Filed Aug 15, 2024 01:05 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
SaleCommon Stock 3,956 $116.67 $461,546.52
Disclosure

SEC source: 0001415889-24-021326 · form4-08142024_090801.xml · nonDerivative · entry 2

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 114,606

F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on August 12, 2022.

Read SEC document
August 12, 2024 Filed Aug 15, 2024 01:05 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
GrantCommon Stock 10,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-021326 · form4-08142024_090801.xml · nonDerivative · entry 1

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,562

F1 · shares: On August 12, 2022, the Reporting Person was granted performance-based Restricted Stock Units (RSUs) covering 50,000 shares of Common Stock vesting in tranches upon the Issuer achieving certain specified financial and operating metrics. On August 12, 2024, the achievement of milestones for the vesting of RSUs covering 10,000 shares of Common Stock was certified.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
August 12, 2024 Filed Aug 15, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 220 $115.70 $25,454.00
Disclosure

SEC source: 0001415889-24-021327 · form4-08142024_090803.xml · nonDerivative · entry 4

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 299,441

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

Read SEC document
August 12, 2024 Filed Aug 15, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 480 $115.07 $55,234.42
Disclosure

SEC source: 0001415889-24-021327 · form4-08142024_090803.xml · nonDerivative · entry 3

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 299,661

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.63 to $115.35 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 12, 2024 Filed Aug 15, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 781 $114.11 $89,118.66
Disclosure

SEC source: 0001415889-24-021327 · form4-08142024_090803.xml · nonDerivative · entry 2

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 300,141

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.58 to $114.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 12, 2024 Filed Aug 15, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 1,219 $112.80 $137,506.61
Disclosure

SEC source: 0001415889-24-021327 · form4-08142024_090803.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 300,922

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.29 to $113.19 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 08, 2024 Filed Aug 10, 2024 01:40 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
Exercise / conversionStock Option (right to buy) · Derivative 190,000 $0.00 Strike: $5.40 $0.00
Disclosure

SEC source: 0001415889-24-021064 · form4-08092024_090801.xml · derivative · entry 4

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 208,496

Underlying: Common Stock · 190,000 shares

Expires 2024-12-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
August 08, 2024 Filed Aug 10, 2024 01:40 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
Exercise / conversionCommon Stock 190,000 $5.40 $1,025,107.00
Disclosure

SEC source: 0001415889-24-021064 · form4-08092024_090801.xml · nonDerivative · entry 1

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,480,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2024 Filed Aug 1, 2024 01:05 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 100 $0.00 Strike: $5.40 $0.00
Disclosure

SEC source: 0001415889-24-020484 · form4-07312024_090707.xml · derivative · entry 3

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100 shares

Expires 2024-12-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
July 31, 2024 Filed Aug 1, 2024 01:05 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
Exercise / conversionCommon Stock 100 $5.40 $539.53
Disclosure

SEC source: 0001415889-24-020484 · form4-07312024_090707.xml · nonDerivative · entry 2

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,562

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2024 Filed Aug 1, 2024 01:05 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 1,866 $99.65 $185,946.90
Disclosure

SEC source: 0001415889-24-020482 · form4-07312024_090701.xml · nonDerivative · entry 2

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,955

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.

Read SEC document
July 29, 2024 Filed Aug 1, 2024 01:05 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
SaleCommon Stock 929 $102.77 $95,469.34
Disclosure

SEC source: 0001415889-24-020484 · form4-07312024_090707.xml · nonDerivative · entry 1

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,462

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.

Read SEC document
July 29, 2024 Filed Aug 1, 2024 01:05 UTC
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
SaleCommon Stock 1,196 $102.77 $122,907.78
Disclosure

SEC source: 0001415889-24-020485 · form4-07312024_090710.xml · nonDerivative · entry 1

Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,441

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.

Read SEC document
July 29, 2024 Filed Aug 1, 2024 01:05 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 4,084 $102.77 $419,695.12
Disclosure

SEC source: 0001415889-24-020483 · form4-07312024_090705.xml · nonDerivative · entry 1

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,293

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.

Read SEC document
July 29, 2024 Filed Aug 1, 2024 01:05 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 1,238 $102.77 $127,223.94
Disclosure

SEC source: 0001415889-24-020482 · form4-07312024_090701.xml · nonDerivative · entry 1

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,821

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.

Read SEC document
July 29, 2024 Filed Aug 1, 2024 01:05 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 1,057 $102.77 $108,623.34
Disclosure

SEC source: 0001415889-24-020486 · form4-07312024_090712.xml · nonDerivative · entry 1

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,400

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.

Read SEC document
July 26, 2024 Filed Jul 27, 2024 01:40 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 751 $102.18 $76,737.18
Disclosure

SEC source: 0001415889-24-020231 · form4-07262024_090701.xml · nonDerivative · entry 3

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,059

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

Read SEC document
July 26, 2024 Filed Jul 30, 2024 21:05 UTC
HEALY JAMESDirector
GrantCommon Stock 177 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-020384 · form4-07302024_090708.xml · nonDerivative · entry 1

HEALY JAMES · CIK 0001245624 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,851

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $19,375 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
July 26, 2024 Filed Jul 31, 2024 01:05 UTC GrantCommon Stock 206 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-020385 · form4-07302024_090710.xml · nonDerivative · entry 1

ROSENMAN HERM · CIK 0001230057 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,587

F1 · shares: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $22,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
July 26, 2024 Filed Jul 31, 2024 01:05 UTC
BOTHA ROELOFDirector
GrantCommon Stock 234 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-020383 · form4-07302024_090705.xml · nonDerivative · entry 1

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,564

F1 · shares: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $25,625 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
July 26, 2024 Filed Jul 31, 2024 01:05 UTC GrantCommon Stock 143 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-020382 · form4-07302024_090702.xml · nonDerivative · entry 1

Baynes Roy D. · CIK 0001680739 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,683

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $15,625 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance.

F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
July 25, 2024 Filed Jul 27, 2024 01:40 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 690 $105.29 $72,650.10
Disclosure

SEC source: 0001415889-24-020231 · form4-07262024_090701.xml · nonDerivative · entry 2

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,810

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

Read SEC document
July 24, 2024 Filed Jul 27, 2024 01:40 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 918 $105.53 $96,876.54
Disclosure

SEC source: 0001415889-24-020231 · form4-07262024_090701.xml · nonDerivative · entry 1

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,500

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

Read SEC document
July 23, 2024 Filed Jul 24, 2024 01:40 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 499 $107.40 $53,591.55
Disclosure

SEC source: 0001415889-24-020012 · form4-07232024_090702.xml · nonDerivative · entry 5

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 77,418

F4 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on October 22, 2021.

Read SEC document
July 22, 2024 Filed Jul 24, 2024 01:05 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
SaleCommon Stock 549 $105.16 $57,732.40
Disclosure

SEC source: 0001415889-24-020009 · form4-07232024_090709.xml · nonDerivative · entry 1

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,391

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.73 to $105.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 22, 2024 Filed Jul 24, 2024 01:05 UTC
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
SaleCommon Stock 549 $105.16 $57,732.68
Disclosure

SEC source: 0001415889-24-020010 · form4-07232024_090711.xml · nonDerivative · entry 1

Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,637

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.9850 to $105.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 22, 2024 Filed Jul 24, 2024 01:40 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 1,250 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-020012 · form4-07232024_090702.xml · derivative · entry 8

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F7 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

F7 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

Read SEC document
July 22, 2024 Filed Jul 24, 2024 01:40 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 1,059 $105.16 $111,364.02
Disclosure

SEC source: 0001415889-24-020012 · form4-07232024_090702.xml · nonDerivative · entry 4

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 77,917

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022, respectively..

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.90 to $105.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.